Goto H, Nomiyama T, Mita T, Yasunari E, Azuma K, Komiya K, Arakawa M, Jin WL, Kanazawa A, Kawamori R, Fujitani Y, Hirose T, Watada H: Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces intimal thickening after vascular injury
Perhaps in this population, the slow gastric emptying effects are additive, creating more gastroparesis and increasing the likelihood of reflux
13.Armstrong MJ, Gaunt P, Aithal GP, Barton D, Hull D, Parker R, et al
[DOI] [PubMed] [Google Scholar] 29.Jorsal A, Kistorp C, Holmager P, et al
Strategic partnerships between established players and regional distributors will likely accelerate global market penetration
No pharmacological overlap washout is needed because both drugs are GLP-1 agonists, though re-escalating through the full semaglutide dose ladder is recommended to minimize GI side effects